136 related articles for article (PubMed ID: 18417986)
1. Organic acid concentrations in amniotic fluid found in normal and Down syndrome pregnancies.
Baggot PJ; Eliseo AJ; DeNicola NG; Kalamarides JA; Shoemaker JD
Fetal Diagn Ther; 2008; 23(3):245-8. PubMed ID: 18417986
[TBL] [Abstract][Full Text] [Related]
2. Pyridoxine-related metabolite concentrations in normal and Down syndrome amniotic fluid.
Baggot PJ; Eliseo AJ; DeNicola NG; Kalamarides JA; Shoemaker JD
Fetal Diagn Ther; 2008; 23(4):254-7. PubMed ID: 18417989
[TBL] [Abstract][Full Text] [Related]
3. A folate-dependent metabolite in amniotic fluid from pregnancies with normal or trisomy 21 chromosomes.
Baggot PJ; Eliseo AJ; Kalamarides JA; Shoemaker JD
Fetal Diagn Ther; 2006; 21(1):148-52. PubMed ID: 16354994
[TBL] [Abstract][Full Text] [Related]
4. S100B content and SOD activity in amniotic fluid of pregnancies with Down syndrome.
Netto CB; Siqueira IR; Fochesatto C; Portela LV; da Purificação Tavares M; Souza DO; Giugliani R; Gonçalves CA
Clin Biochem; 2004 Feb; 37(2):134-7. PubMed ID: 14725944
[TBL] [Abstract][Full Text] [Related]
5. Decreased levels of amniotic fluid alpha-fetoprotein associated with Down syndrome.
Davis RO; Cosper P; Huddleston JF; Bradley EL; Finley SC; Finley WH; Milunsky A
Am J Obstet Gynecol; 1985 Nov; 153(5):541-4. PubMed ID: 2414991
[TBL] [Abstract][Full Text] [Related]
6. Decreased amniotic fluid leptin levels in the second trimester in Down's syndrome.
Choi TY; Kim S; An BM; Jeong SY; Moon HS; Joo BS
Fetal Diagn Ther; 2009; 26(4):195-9. PubMed ID: 19940449
[TBL] [Abstract][Full Text] [Related]
7. Metabolic profile of amniotic fluid as a biochemical tool to screen for inborn errors of metabolism and fetal anomalies.
Amorini AM; Giorlandino C; Longo S; D'Urso S; Mesoraca A; Santoro ML; Picardi M; Gullotta S; Cignini P; Lazzarino D; Lazzarino G; Tavazzi B
Mol Cell Biochem; 2012 Jan; 359(1-2):205-16. PubMed ID: 21837404
[TBL] [Abstract][Full Text] [Related]
8. Do amniotic fluid leptin levels decrease in pregnancies with fetal trisomy 21?
Demir A; Saatli B; Cagliyan E; Solak A; Guclu S
J Obstet Gynaecol; 2012 Aug; 32(6):540-2. PubMed ID: 22779957
[TBL] [Abstract][Full Text] [Related]
9. Intrauterine diagnosis of genetic disorders.
Danks DM
Aust Paediatr J; 1972 Jun; 8(3):128-30. PubMed ID: 4264596
[No Abstract] [Full Text] [Related]
10. Specificity and sensitivity of S100B levels in amniotic fluid for Down syndrome diagnosis.
Tort AB; Portela LV; da Purificação Tavares M; Gonçalves CA; Netto C; Giugliani R; Souza DO
Life Sci; 2004 Dec; 76(4):379-84. PubMed ID: 15530500
[TBL] [Abstract][Full Text] [Related]
11. Prenatal diagnosis for organic acid disorders using two mass spectrometric methods, gas chromatography mass spectrometry and tandem mass spectrometry.
Hasegawa Y; Iga M; Kimura M; Shigematsu Y; Yamaguchi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 823(1):13-7. PubMed ID: 15908288
[TBL] [Abstract][Full Text] [Related]
12. Comparative proteomic analysis of human amniotic fluid supernatants with Down syndrome using mass spectrometry.
Park J; Cha DH; Jung JW; Kim YH; Lee SH; Kim Y; Kim KP
J Microbiol Biotechnol; 2010 Jun; 20(6):959-67. PubMed ID: 20622492
[TBL] [Abstract][Full Text] [Related]
13. Prenatal diagnosis of methylmalonic aciduria by analysis of organic acids and total homocysteine in amniotic fluid.
Zhang Y; Yang YL; Hasegawa Y; Yamaguchi S; Shi CY; Song JQ; Sayami S; Liu P; Yan R; Dong JH; Qin J
Chin Med J (Engl); 2008 Feb; 121(3):216-9. PubMed ID: 18298912
[TBL] [Abstract][Full Text] [Related]
14. Resistin in mid-trimester amniotic fluid in trisomy 21.
Vrachnis N; Gkogkas L; Iliodromiti S; Grigoriadis C; Samoli E; Iliodromiti Z; Pangalos C; Pappa KI; Drakoulis N; Creatsas G; Botsis D
J Matern Fetal Neonatal Med; 2013 Nov; 26(16):1576-80. PubMed ID: 23544842
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum and amniotic fluid levels of macrophage inhibitory cytokine 1 in Down syndrome and chromosomally normal pregnancies.
Wallace EM; Marjono B; Brown DA; Crossley J; Tong S; Aitken D; Breit S
Prenat Diagn; 2004 Mar; 24(3):224-6. PubMed ID: 15057958
[TBL] [Abstract][Full Text] [Related]
16. Maternal plasma and amniotic fluid sphingolipids profiling in fetal Down syndrome.
Charkiewicz K; Blachnio-Zabielska A; Zbucka-Kretowska M; Wolczynski S; Laudanski P
PLoS One; 2015; 10(5):e0127732. PubMed ID: 26000716
[TBL] [Abstract][Full Text] [Related]
17. Development of a multiplex selected reaction monitoring assay for quantification of biochemical markers of down syndrome in amniotic fluid samples.
Martínez-Morillo E; Cho CK; Drabovich AP; Shaw JL; Soosaipillai A; Diamandis EP
J Proteome Res; 2012 Jul; 11(7):3880-7. PubMed ID: 22681384
[TBL] [Abstract][Full Text] [Related]
18. [Prenatal diagnosis of genetic defects from the amniotic fluid. Report of experiences].
Körner H; Halle H; Wagenknecht C
Zentralbl Gynakol; 1977; 99(12):725-34. PubMed ID: 70907
[TBL] [Abstract][Full Text] [Related]
19. Elevated amniotic fluid amino acid levels in fetuses with gastroschisis.
Kale A; Kale E; Akdeniz N; Canoruc N
Braz J Med Biol Res; 2006 Aug; 39(8):1021-5. PubMed ID: 16906276
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA Expression Profile in the Prenatal Amniotic Fluid Samples of Pregnant Women with Down Syndrome.
Karaca E; Aykut A; Ertürk B; Durmaz B; Güler A; Büke B; Yeniel AÖ; Ergenoğlu AM; Özkınay F; Özeren M; Kazandı M; Akercan F; Sağol S; Gündüz C; Çoğulu Ö
Balkan Med J; 2018 Mar; 35(2):163-166. PubMed ID: 29219113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
